Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI

NCT04981041 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2334

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Atrial Fibrillation

Interventions

DRUG: Prasugrel or Ticagrelor
DRUG: Clopidogrel

Sponsor

Ludwig-Maximilians - University of Munich